Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.

Jones DA. et al, (2024), Br J Haematol

Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.

Jones DA. et al, (2023), Clin Oncol (R Coll Radiol), 35, 301 - 310

P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in England

Jones D. et al, (2022), HemaSphere, 6, 43 - 44

Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.

Jones DA. et al, (2022), Blood Adv, 6, 909 - 919

Include forthcoming?